Company Email Format Management

AVEO Oncology

Biotechnology Research 30 Winter St 200 employees

Employees: 200
Contacts: 3
Emails: 3
Phones: 1

aveooncology.com LinkedIn Crunchbase

AVEO Oncology Overview

Headquarters: 30 Winter St
Phone Number: Available in AeroLeads
Website: aveooncology.com
Industry: Biotechnology Research
Employees: 200
Founded: 2001
Funding: 55.2M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Oncology

About AVEO Oncology

AVEO is a commercial-stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer. AVEO currently markets FOTIVDA® (tivozanib) in the U.S. for the treatment of adult patients with relapsed or refractory renal cell carcinoma (RCC) following two or more prior systemic therapies. AVEO continues to develop FOTIVDA in immuno-oncology combinations in RCC and other indications, and has other investigational programs in clinical development. AVEO is committed to creating an environment of diversity, equity and inclusion to diversify representation within the Company.

AVEO Oncology Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

AVEO Oncology Org Chart

Sample employees and titles

Name	Title	Location	Contact
Ken Kirsch	Market Insights Leader Driving Bottom Line Results Via the Intersection of Market Research, Analytics, Portfolio Planning and Competitive		View
Arlyssa Laporte		Swampscott, Massachusetts, United States	Email
Samuel Villa	Senior Director, Federal Markets Aveo Oncology an LG Chem Company	Mckinney, Texas, United States	Email
Deb Wall	People - Culture - Leadership - Development - Engagement - Operational Excellence	Greater Boston, United States	Email Phone